Market Tracker

08/26 4:24am ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.33
Delayed Data
As of Aug 25
 -0.07 / -5.00%
Today’s Change
1.23
Today|||52-Week Range
2.31
-31.44%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.40
Today’s open1.37
Day’s range1.33 - 1.40
Volume2,882
Average volume (3 months)41,992
Market cap$54.1M
Dividend yield--
Data as of 08/25/2016

Growth & Valuation

Earnings growth (last year)-54.29%
Earnings growth (this year)+61.11%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-64.19%
P/E ratioNM
Price/Sales2.98
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd0.000.00%
NVETNexvet Biopharma plc-0.41-8.57%
PVCTProvectus Biopharmac...-0.12-49.76%
RNNRexahn Pharmaceutica...-0.00-0.50%
Data as of 08/25/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)$0.23
Annual revenue (last year)$24.6M
Annual profit (last year)-$19.1M
Net profit margin-77.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts